BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 21693620)

  • 1. Inhibition of eukaryotic translation elongation by the antitumor natural product Mycalamide B.
    Dang Y; Schneider-Poetsch T; Eyler DE; Jewett JC; Bhat S; Rawal VH; Green R; Liu JO
    RNA; 2011 Aug; 17(8):1578-88. PubMed ID: 21693620
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Discovery of C13-Aminobenzoyl Cycloheximide Derivatives that Potently Inhibit Translation Elongation.
    Koga Y; Hoang EM; Park Y; Keszei AFA; Murray J; Shao S; Liau BB
    J Am Chem Soc; 2021 Sep; 143(34):13473-13477. PubMed ID: 34403584
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Natural products targeting the elongation phase of eukaryotic protein biosynthesis.
    Brönstrup M; Sasse F
    Nat Prod Rep; 2020 Jun; 37(6):752-762. PubMed ID: 32428051
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of eukaryotic translation elongation by cycloheximide and lactimidomycin.
    Schneider-Poetsch T; Ju J; Eyler DE; Dang Y; Bhat S; Merrick WC; Green R; Shen B; Liu JO
    Nat Chem Biol; 2010 Mar; 6(3):209-217. PubMed ID: 20118940
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of the active aldehyde group generated by RNA N-glycosidase in the sarcin/ricin domain of rat 28S ribosomal RNA on peptide elongation.
    Xu YZ; Liu WY
    Biol Chem; 2000 Feb; 381(2):113-9. PubMed ID: 10746742
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of Eukaryotic Translation by the Antitumor Natural Product Agelastatin A.
    McClary B; Zinshteyn B; Meyer M; Jouanneau M; Pellegrino S; Yusupova G; Schuller A; Reyes JCP; Lu J; Guo Z; Ayinde S; Luo C; Dang Y; Romo D; Yusupov M; Green R; Liu JO
    Cell Chem Biol; 2017 May; 24(5):605-613.e5. PubMed ID: 28457705
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Eukaryotic translation elongation factor 2 (eEF2) catalyzes reverse translocation of the eukaryotic ribosome.
    Susorov D; Zakharov N; Shuvalova E; Ivanov A; Egorova T; Shuvalov A; Shatsky IN; Alkalaeva E
    J Biol Chem; 2018 Apr; 293(14):5220-5229. PubMed ID: 29453282
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mycalamides, pederin and psymberin as natural carbohydrates and potential antitumor agents: past and future perspectives.
    Witczak ZJ; Rampulla RM; Bommareddy A
    Mini Rev Med Chem; 2012 Dec; 12(14):1520-32. PubMed ID: 22827176
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Natural products as drugs and tools for influencing core processes of eukaryotic mRNA translation.
    Burgers LD; Fürst R
    Pharmacol Res; 2021 Aug; 170():105535. PubMed ID: 34058326
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Binding mode of the first aminoacyl-tRNA in translation initiation mediated by Plautia stali intestine virus internal ribosome entry site.
    Yamamoto H; Nakashima N; Ikeda Y; Uchiumi T
    J Biol Chem; 2007 Mar; 282(11):7770-6. PubMed ID: 17209036
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antitumor activity and mechanism of action of the novel marine natural products mycalamide-A and -B and onnamide.
    Burres NS; Clement JJ
    Cancer Res; 1989 Jun; 49(11):2935-40. PubMed ID: 2720652
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structural requirements for the antiproliferative activity of pre-mRNA splicing inhibitor FR901464.
    Osman S; Albert BJ; Wang Y; Li M; Czaicki NL; Koide K
    Chemistry; 2011 Jan; 17(3):895-904. PubMed ID: 21226105
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Versatile Synthetic Route to Cycloheximide and Analogues That Potently Inhibit Translation Elongation.
    Park Y; Koga Y; Su C; Waterbury AL; Johnny CL; Liau BB
    Angew Chem Int Ed Engl; 2019 Apr; 58(16):5387-5391. PubMed ID: 30802354
    [TBL] [Abstract][Full Text] [Related]  

  • 14. mRNA-Independent way to regulate translation elongation rate in eukaryotic cells.
    Negrutskii B; Vlasenko D; Mirande M; Futernyk P; El'skaya A
    IUBMB Life; 2018 Mar; 70(3):192-196. PubMed ID: 29417736
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The in vitro biological activities of synthetic 18-O-methyl mycalamide B, 10-epi-18-O-methyl mycalamide B and pederin.
    Richter A; Kocienski P; Raubo P; Davies DE
    Anticancer Drug Des; 1997 Apr; 12(3):217-27. PubMed ID: 9154112
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The marine polyketide myriaporone 3/4 stalls translation by targeting the elongation phase.
    Muthukumar Y; Roy M; Raja A; Taylor RE; Sasse F
    Chembiochem; 2013 Jan; 14(2):260-4. PubMed ID: 23303710
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Divergent tRNA-like element supports initiation, elongation, and termination of protein biosynthesis.
    Jan E; Kinzy TG; Sarnow P
    Proc Natl Acad Sci U S A; 2003 Dec; 100(26):15410-5. PubMed ID: 14673072
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The pederin family of antitumor agents: structures, synthesis and biological activity.
    Narquizian R; Kocienski PJ
    Ernst Schering Res Found Workshop; 2000; (32):25-56. PubMed ID: 11077605
    [No Abstract]   [Full Text] [Related]  

  • 19. Structures of triacetyloleandomycin and mycalamide A bind to the large ribosomal subunit of Haloarcula marismortui.
    Gürel G; Blaha G; Steitz TA; Moore PB
    Antimicrob Agents Chemother; 2009 Dec; 53(12):5010-4. PubMed ID: 19738021
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Specific inhibition of translocation by tubulosine in eukaryotic polysomes.
    Carrasco L; Jimenez A; Vázquez D
    Eur J Biochem; 1976 Apr; 64(1):1-5. PubMed ID: 776609
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.